论文部分内容阅读
血管紧张素转化酶（ＡＣＥ）抑制剂是治疗高血压的一线药物，又是心梗后二级预防及治疗心衰和糖尿病微蛋白尿的有效药物。最近发现，ＡＣＥ抑制剂能降低充血性心衰病人的循环血管细胞粘附分子－１（ｃＶＣＡＭ－１）的血浆浓度。ｃＶＣＡＭ－１，细胞间粘附分子－１（ｃＩＣＡ
Angiotensin-converting enzyme (ACE) inhibitors are first-line drugs for the treatment of hypertension and secondary drugs for the prevention and treatment of heart failure and diabetic microalbuminuria after myocardial infarction. Recently, ACE inhibitors have been shown to decrease plasma concentrations of circulating vascular cell adhesion molecule-1 (cVCAM-1) in patients with congestive heart failure. cVCAM-1, intercellular adhesion molecule-1 (cICA